Table 2 Analysis of BCR-ABL -expressing... | American Society of Hematology

Table 2

Analysis of BCR-ABL-expressing cells in CFU-C and LTC-IC assays

Patient	Clonogenic assays at day 0*		Clonogenic assays on LTC-IC (week 5)†				Tested colonies
	Individual CFU-Cs	Pools of 10 CFU-Cs	Individual LTC-ICs		Pools of 10 LTC-ICs
	Individual CFU-Cs	Pools of 10 CFU-Cs	MS-5	MS-5/HOXB4	MS-5	MS-5/HOXB4
1	0/20	1/18	4/31		1/8		311
2	0/20	1/19	2/39	4/40	ND	ND	289
3	9/19	11/16	1/30	9/30	ND	ND	239
4	2/20	0/19	0/20		0/19		420
5	1/20	0/20	0/20	2/17	0/20	0/20	657
6	1/17	ND	23/24	12/43	ND	ND	84
Tested colonies	116	920	164	130	470	200	2000

Patient	Clonogenic assays at day 0*		Clonogenic assays on LTC-IC (week 5)†				Tested colonies
	Individual CFU-Cs	Pools of 10 CFU-Cs	Individual LTC-ICs		Pools of 10 LTC-ICs
	Individual CFU-Cs	Pools of 10 CFU-Cs	MS-5	MS-5/HOXB4	MS-5	MS-5/HOXB4
1	0/20	1/18	4/31		1/8		311
2	0/20	1/19	2/39	4/40	ND	ND	289
3	9/19	11/16	1/30	9/30	ND	ND	239
4	2/20	0/19	0/20		0/19		420
5	1/20	0/20	0/20	2/17	0/20	0/20	657
6	1/17	ND	23/24	12/43	ND	ND	84
Tested colonies	116	920	164	130	470	200	2000

ND indicates not done (insufficient clonogenic or LTC-IC–derived CFU-C growth).

Number of BCR-ABL–positive CFU-Cs per tested CFU-Cs.

Number of BCR-ABL–positive LTC-ICs per tested LTC-ICs.